Stockscreener 앱 받기
3.08
7.69%
0.22
시간 외 거래:
3.11
0.03
+0.97%
전일 마감가:
$2.86
열려 있는:
$2.8
하루 거래량:
3.77M
Relative Volume:
1.11
시가총액:
$463.14M
수익:
$2.82M
순이익/손실:
$-114.60M
주가수익비율:
-3.4063
EPS:
-0.9042
순현금흐름:
$-81.94M
1주 성능:
+33.91%
1개월 성능:
+10.79%
6개월 성능:
+18.01%
1년 성능:
+3.36%
1일 변동 폭
$2.79
$3.14
1주일 범위
$2.31
$3.14
52주 변동 폭
$2.01
$5.228
Absci Corp Stock (ABSI) Company Profile
명칭
Absci Corp
전화
(360) 949-1041
주소
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.08 | 430.06M | 2.82M | -114.60M | -81.94M | -0.9042 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | 개시 | JP Morgan | Overweight |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-01-22 | 개시 | Needham | Buy |
| 2024-10-02 | 개시 | Guggenheim | Buy |
| 2024-07-03 | 개시 | Morgan Stanley | Overweight |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | 개시 | H.C. Wainwright | Buy |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-07-18 | 개시 | Truist | Buy |
| 2022-03-02 | 재개 | Cowen | Market Perform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-11-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-08-16 | 개시 | BofA Securities | Neutral |
| 2021-08-16 | 개시 | Cowen | Market Perform |
| 2021-08-16 | 개시 | Credit Suisse | Outperform |
| 2021-08-16 | 개시 | Stifel | Hold |
모두보기
Absci Corp 주식(ABSI)의 최신 뉴스
Earnings Preview: Absci Corp to Report Financial Results Post-market on March 24 - 富途牛牛
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Needham Reiterates Buy Rating for Absci (ABSI) with Unchanged Pr - GuruFocus
Absci (NASDAQ:ABSI) Given Buy Rating at Needham & Company LLC - MarketBeat
Heights Capital Management Inc. Makes New Investment in Absci Corporation $ABSI - MarketBeat
Absci Corporation (NASDAQ:ABSI) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Absci (ABSI) CLO receives major RSU and stock option grants - Stock Titan
Absci (NASDAQ: ABSI) CFO receives new RSU and stock option awards - Stock Titan
Absci (NASDAQ: ABSI) SVP Bedrick gets RSUs, options and tax withholding - Stock Titan
Absci (NASDAQ: ABSI) CEO granted 2M+ equity units and has shares withheld for taxes - Stock Titan
Absci Corp chief innovation officer Busch buys $229,000 in stock - Investing.com Australia
Absci Corp chief innovation officer Busch buys $229,000 in stock By Investing.com - Investing.com Canada
Absci (NASDAQ:ABSI) Insider Acquires $229,000.00 in Stock - MarketBeat
Absci (ABSI) innovation chief buys 100K shares at $2.29 each - Stock Titan
Absci Highlights AI Antibody Platform, ABS-201 Hair-Loss Trial Milestones at Leerink Conference - Yahoo Finance
AbSci2026 Funding Rounds & List of Investors - Tracxn
Absci's Andreas Busch to Retire as Chief Innovation Officer, to Serve as Scientific Advisor - TradingView
New Absci medical chief gets option to buy 650,000 company shares - Stock Titan
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Absci (ABSI) director Menelas Pangalos awarded RSUs and stock options - Stock Titan
Absci (NASDAQ: ABSI) CFO reports new RSUs and stock option grant - Stock Titan
Absci (ABSI) CEO Sean McClain receives major equity grants and tax-share withholding - Stock Titan
Absci (ABSI) Chief Innovation Officer has shares withheld for RSU tax obligations - Stock Titan
Absci names Ransi Somaratne as chief medical officer By Investing.com - Investing.com South Africa
Absci (ABSI) CFO has 8,307 shares withheld for RSU tax payment - Stock Titan
Absci Corp (ABSI) director Menelas Pangalos buys 75,095 shares in market - Stock Titan
Tax withholding trims Absci (ABSI) CFO Jonasson’s share count - Stock Titan
Absci (ABSI) CEO has 26,761 shares withheld to cover RSU taxes - Stock Titan
Absci Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - The Manila Times
Absci names Ransi Somaratne as chief medical officer - Investing.com
Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage - Yahoo Finance
ABSI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Activity Recap: Is now the right time to enter Absci Corporation - baoquankhu1.vn
Absci (ABSI) CEO McClain exercises options and withholds shares for taxes - Stock Titan
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - The Manila Times
AI drug developer Absci to reveal 2025 results in March webcast - Stock Titan
Absci Corporation (NASDAQ:ABSI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ABSI stock up on initiating dosing in androgenetic alopecia study - MSN
ABSI Technical Analysis & ETF Price Forecast - Intellectia AI
Absci to Participate in Upcoming Investor Conferences - 富途牛牛
AI-driven drug developer Absci lines up four March investor events - Stock Titan
In the Wake of Absci Corporation's (NASDAQ:ABSI) Latest US$75m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛
Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble - simplywall.st
Absci (NASDAQ: ABSI) SVP has shares withheld to cover RSU taxes - Stock Titan
OpenAI considers backing AI-led drug discovery firms: report - Seeking Alpha
Absci Corporation: Drawing Potential Insights On ABS-101 And ABS-201 (NASDAQ:ABSI) - Seeking Alpha
What is Absci Corporation’s valuation compared to sectorFed Meeting & Growth Focused Stock Reports - mfd.ru
Absci Corporation (NASDAQ:ABSI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Absci Corporation's (NASDAQ:ABSI) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance
Sentiment Review: Is Charter Communications Inc stock a buy or sellBull Run & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Absci Corp (ABSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):